Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Comparison of Assisted Reproductive Technology Cycle Outcomes Among Daily Buserelin, Daily, and Every Other Day Triptorelin in Infertile Patients Referring to Imam Khomeini Hospital Complex: A Randomized Controlled Trial Publisher



Tehraninejad ES1 ; Nekoo ZA1 ; Nekoo EA2 ; Kalantari V3 ; Tarafdari A1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Obstetrics and Gynecology, Vali-e-asr Reproductive Health Research Center, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Internal Medicine, Jacobi Medical Center, Albert Einstein University, New York, United States
  3. 3. Department of Internal Medicine, Faculty of Medicine, American University of Integrative Medicine, Saint Martin, United States

Source: International Journal of Women's Health and Reproduction Sciences Published:2021


Abstract

Objectives: Different types of gonadotropin-releasing hormone (GnRH) agonist protocols are used in assisted reproductive technology (ART) cycles although the role of every other day GnRH agonist administration is not well understood. Thus, this study compared the effectiveness of different ways of the administration of GnRH agonists in the ovarian stimulation long protocol and their effects on in vitro fertilization (IVF) outcomes. Materials and Methods: In a randomized controlled trial (RCT), 138 patients were randomly assigned to 3 groups with 46 patients. In group A, patients were treated with daily buserelin 0.5 mg subcutaneously and those in group B were treated with triptorelin 0.1 mg daily, and finally, patients in group C received triptorelin 0.1 mg every other day (all under a long protocol). Eventually, controlled ovarian stimulation was performed with the follicle-stimulating hormone (FSH). Results: There was no significant difference in biochemical and clinical pregnancy, along with abortion and twin rates between the comparison groups. Meanwhile, the number of gonadotropin injections was significantly lower in group C (P = 0.033). Moreover, the number of follicles and days of ovarian stimulation did not have a significant difference between study groups. Finally, the number of metaphase 2 oocytes and embryos was significantly higher in group A (P = 0.001). Conclusions: In general, pregnancy and abortion rates did not significantly differ between the comparison groups and, the number of gonadotropin injections was significantly lower in the triptorelin 0.1 mg every other day group. Thus, our finding revealed that every other day use of triptorelin 0.1 mg, comparing its daily use or daily buserelin, might be cost-benefit. © 2021 The Author(s);.
Related Docs
Experts (# of related papers)